Cargando…

Effect of MAOA DNA Methylation on Human in Vivo Protein Expression Measured by [(11)C]harmine Positron Emission Tomography

BACKGROUND: Epigenetic modifications like DNA methylation are understood as an intermediary between environmental factors and neurobiology. Cerebral monoamine oxidase A (MAO-A) levels are altered in depression, as are DNA methylation levels within the MAOA gene, particularly in the promoter/exon I/i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handschuh, Patricia A, Murgaš, Matej, Vraka, Chrysoula, Nics, Lukas, Hartmann, Annette M, Winkler-Pjrek, Edda, Baldinger-Melich, Pia, Wadsak, Wolfgang, Winkler, Dietmar, Hacker, Marcus, Rujescu, Dan, Domschke, Katharina, Lanzenberger, Rupert, Spies, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926052/ https://www.ncbi.nlm.nih.gov/pubmed/36573644 http://dx.doi.org/10.1093/ijnp/pyac085

Ejemplares similares

Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo
por: Spies, Marie, et al.
Publicado: (2023)

PS186. Light exposure and seasonal variation of the serotonin degrading enzyme monoamine oxidase A in the healthy human brain revealed by PET
por: Hienert, Marius, et al.
Publicado: (2016)

Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy
por: Spies, Marie, et al.
Publicado: (2018)

Simultaneous radiomethylation of [(11)C]harmine and [(11)C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual
por: Vraka, Chrysoula, et al.
Publicado: (2022)

Effects of bilateral sequential theta-burst stimulation on 5-HT(1A) receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial
por: Murgaš, Matej, et al.
Publicado: (2023)

Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[(11)C]Me-NB1
por: Rischka, Lucas, et al.
Publicado: (2022)

Prescriptions of psychopharmacologic drugs in Austria in 2019 and 2020 – Implications of the COVID-19 pandemic
por: Winkler, Dietmar, et al.
Publicado: (2022)

Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials
por: Philippe, C., et al.
Publicado: (2015)

Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo
por: James, Gregory M, et al.
Publicado: (2019)

ABCB1 variants and sex affect serotonin transporter occupancy in the brain
por: Silberbauer, Leo R., et al.
Publicado: (2022)

Alcohol consumption in Austrian physicians
por: Pjrek, Edda, et al.
Publicado: (2019)

Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity
por: Hahn, Andreas, et al.
Publicado: (2017)

Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI
por: Rami-Mark, Christina, et al.
Publicado: (2015)

On the Road towards Small-Molecule Programmed Cell Death 1 Ligand 1 Positron Emission Tomography Tracers: A Ligand-Based Drug Design Approach
por: Bamminger, Karsten, et al.
Publicado: (2023)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
por: Kautzky, A, et al.
Publicado: (2017)

SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [(18)F]FE@SNAP and [(11)C]SNAP-7941
por: Philippe, Cécile, et al.
Publicado: (2018)

Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Effects of Silexan on the Serotonin-1A Receptor and Microstructure of the Human Brain: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study with Molecular and Structural Neuroimaging
por: Baldinger, Pia, et al.
Publicado: (2015)

PS183. Effect of electroconvulsive therapy on monoamine oxidase A binding - a preliminary report
por: Baldinger-Melich, Pia, et al.
Publicado: (2016)

Association of dopamine D(2/3) receptor binding potential measured using PET and [(11)C]-(+)-PHNO with post-mortem DRD(2/3) gene expression in the human brain
por: Komorowski, Arkadiusz, et al.
Publicado: (2020)

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
por: Spies, Marie, et al.
Publicado: (2017)

Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
por: Konadu, Melisande E., et al.
Publicado: (2023)

Plasticity of Functional MAOA Gene Methylation in Acrophobia
por: Schiele, Miriam A, et al.
Publicado: (2018)

Prevention of seasonal affective disorder in daily clinical practice: results of a survey in German-speaking countries
por: Nussbaumer-Streit, B., et al.
Publicado: (2017)

Pitfalls and solutions of the fully-automated radiosynthesis of [(11)C]metoclopramide
por: Pichler, Verena, et al.
Publicado: (2019)

High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People
por: Kranz, Georg S., et al.
Publicado: (2015)

Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge
por: Klöbl, Manfred, et al.
Publicado: (2020)

Exploring the Impact of BDNF Val66Met Genotype on Serotonin Transporter and Serotonin-1A Receptor Binding
por: Kraus, Christoph, et al.
Publicado: (2014)

PS168. Hybrid PET/MR imaging of serotonin transporter occupancy and brain activation to elucidate the mechanism of action of selective serotonin reuptake inhibitors
por: Gryglewski, G, et al.
Publicado: (2016)

Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial
por: Höflich, Anna, et al.
Publicado: (2021)

Implementing prevention of seasonal affective disorder from patients’ and physicians’ perspectives – a qualitative study
por: Nussbaumer-Streit, Barbara, et al.
Publicado: (2018)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

Comparison of cardiac image-derived input functions for quantitative whole body [(18)F]FDG imaging with arterial blood sampling
por: Reed, Murray Bruce, et al.
Publicado: (2023)

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET
por: Lanzenberger, R, et al.
Publicado: (2013)

Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1
por: Ozenil, Marius, et al.
Publicado: (2020)

Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1)
por: Philippe, Cécile, et al.
Publicado: (2013)

Changes in White Matter Microstructure After Electroconvulsive Therapy for Treatment-Resistant Depression
por: Gryglewski, Gregor, et al.
Publicado: (2019)

[(18)F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents
por: Haeusler, Daniela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_177evqj11lpemcvvo1l20g1plm